Homology Medicines, Inc.

NasdaqGS:FIXX Stock Report

Mkt Cap: US$97.1m

Homology Medicines Financial Health

How is Homology Medicines's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: FIXX's short term assets ($213.2M) exceed its short term liabilities ($25.3M).

Long Term Liabilities: FIXX's short term assets ($213.2M) exceed its long term liabilities ($28.3M).


Debt to Equity History and Analysis

Debt Level: FIXX is debt free.

Reducing Debt: FIXX has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FIXX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: FIXX has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 27.4% each year.


Discover healthy companies